Ketorolac IV
Phase 3Small molecule
Ketorolac IV is one of 7 small molecule programs targeting Embryo Transfer. It is currently in Phase 3.
1
Indications
3
Total Trials
2
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Embryo Transfer
#DrugCompanyPhaseTrials
1Gnrh Agonist
Johnson & JohnsonPhase 3
Hcg
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 3
Ketorolac IV
IIslamabad Medical and Dental College
Phase 3
Tractocile
GSKPreclinical
Clomid
EMD SeronoPreclinical
Gnrh Ant
Merck & Co.Preclinical
The Platelet Rich Plasma（prp）
PPeking University Third Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Mastectomy1 trial
Embryo Transfer1 trial
Ketorolac Use and Fresh Embryo Transfer Outcomes
Recruiting·—·Phase 4·NCT07185724·200 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Ketorolac IV. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details